HIGHLIGHTS
- who: Methotrexate and colleagues from the Department of Ophthalmology, Truhlsen Eye Institute, University USA have published the article: International Journal Clinical outcomes following for primary vitreoretinal lymphoma, in the Journal: (JOURNAL)
SUMMARY
Protocols utilized by clinicians have varied in the literature. Knowledge gaps remain regarding visual outcomes associated with MTX injection protocols after diagnosis, relapse and remission rates, and tolerability. Patient records were reviewed for demographic information, ocular exam findings, disease presentation and course, and treatment regimens including number of methotrexate (MTX) injections. Clinical outcomes recorded included initial and final visual acuity (VA . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.